All | Group 1 | Group 2 | Group 3 | Group 4 | P- values | |
---|---|---|---|---|---|---|
(N = 203) | (N = 46) | (N = 64) | (N = 64) | (N = 29) | ||
Age (years) | ||||||
0–1 | 15 (7%) | 5 (11%) | 7 (11%) | 2 (3%) | 1 (3%) | 0.198 |
1–5 | 56 (28%) | 15 (33%) | 20 (31%) | 13 (20%) | 8 (28%) | |
5–10 | 98 (48%) | 15 (33%) | 28 (44%) | 39 (61%) | 16 (55%) | |
>10 | 34 (17%) | 11 (23%) | 9 (14%) | 10 (16%) | 4 (14%) | |
Gender male | 132(65%) | 27 (59%) | 44 (69%) | 45 (70%) | 16 (55%) | 0.358 |
Underlying medical conditions | 0.004 | |||||
none | 60 (30%) | 13 (28%) | 16 (25%) | 24 (38%) | 7 (24%) | |
asthma | 57 (28%) | 8 (17%) | 20 (31%) | 22 (34%) | 7 (24%) | |
asthmatic diseases+ | 29 (14%) | 2 (5%) | 10 (16%) | 9 (14%) | 8 (28%) | |
other respiratory problems++ | 8 (4%) | 3 (6%) | 2 (3%) | 2 (3%) | 1 (4%) | |
immunocompromised * | 4 (2%) | 2 (5%) | 0 (0%) | 2 (3%) | 0 (0%) | |
others** | 45 (22%) | 18 (39%) | 16 (25%) | 5 (8%) | 6 (20%) | |
Heart Rate on admission | 146 | 138 | 150 | 150 | 150 | 0.072 |
(bpm, median) IQR | 133-160 | 100-175 | 128-172 | 121-179 | 128-172 | |
Respiratory Rate on admission | 37 | 24 | 40 | 38 | 40 | < 0.001 |
(bpm, median) IQR | 28-42 | 14-34 | 20-60 | 23-53 | 17-63 | |
Body Temperature on admission | 38.5 | 38.7 | 38.4 | 38.4 | 38.2 | 0.530 |
(°C, median) IQR | 37.9-39.2 | 37.4-40.0 | 37.3-39.5 | 37.0-39.8 | 36.6-39.9 | |
SpO2 on admission | 94 | 98 | 96 | 93 | 94 | < 0.001 |
(%, median) IQR | 93-98 | 95-100 | 91-100 | 88-98 | 88-100 | |
O2 demand on admission YES | 39 (19%) | 4 (9%) | 9 (14%) | 19 (30%) | 7 (24%) | 0.025 |
O2 demand during admission YES | 129 (64%) | 10 (22%) | 41 (64%) | 53 (83%) | 25 (86%) | 0.002 |
Time from the onset of illness (hr) | ||||||
0–5 | 38 (19%) | 11(23%) | 14 (22%) | 11 (17%) | 2 (7%) | 0.976 |
6–11 | 27 (13%) | 1 (2%) | 8 (12%) | 13 (20%) | 5 (17%) | |
12–23 | 61 (30%) | 18 (41%) | 14 (22%) | 15 (23%) | 14 (49%) | |
24–47 | 42 (21%) | 11 (23%) | 13 (20%) | 11 (17%) | 7 (24%) | |
48 - | 20 (10%) | 3 (7%) | 8 (12%) | 9 (14%) | 0 (0%) | |
Unknown | 15 (7%) | 2 (4%) | 7 (12%) | 5 (9%) | 1 (3%) | |
Systemic steroid use YES | 84 (41%) | 10 (22%) | 24 (38%) | 33 (52%) | 17 (59%) | 0.34 |
Antibiotics use YES | 92 (45%) | 5 (11%) | 23 (36%) | 51 (80%) | 13 (45%) | 0.10 |
Antiviral use YES | 191 (94%) | 42 (91%) | 60 (94%) | 62 (97%) | 27 (93%) | 0.994 |